Last reviewed · How we verify
NCT06029582: VRPASAB
VR Headset for Pain During Pregnancy Termination
NA trial testing VR headset in Pregnancy Termination in 100 participants. Status unknown.
8 June 2024
Quick facts
| Lead sponsor | St. Luke's Hospital, Pennsylvania |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 20 June 2023 |
| Primary completion | 8 June 2024 |
| Estimated completion | 7 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- VR headset
Conditions studied
- Pregnancy Termination — all drugs for Pregnancy Termination →
Sponsor
St. Luke's Hospital, Pennsylvania
Who can join
18 and older, female only, with Pregnancy Termination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized control study is to see if virtual reality headsets (VRHS) are useful in women undergoing surgical pregnancy termination. The main questions it aims to answer are: Do VRHS decrease the pain associated with surgical pregnancy termination Participants will wear the VRHS during the surgery and take a pain survey before and after the procedure. The pain assessment will be compared to placebo headset which will be randomly assigned.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06029582
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of VR headset
Trials testing the same drug.
- NCT06597591 — Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders · NA · recruiting
- NCT06647615 — A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in · NA · recruiting
Other St. Luke's Hospital, Pennsylvania trials
Trials by the same sponsor.
- NCT06806410 — The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery · Phase 4 · active not recruiting
- NCT05494645 — Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial · Phase 4 · unknown
- NCT04910165 — Exparel Use in Adductor Canal Block After Total Knee Arthroplasty · Phase 3 · completed
- NCT03953404 — POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock · unknown
- NCT03876899 — RCT of Evening Primrose Oil for the Treatment of Breastfeeding Pain · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06029582 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Luke's Hospital, Pennsylvania
- Last refreshed: 8 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06029582.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing